Lethality is the capacity of a disease, substance, or event to cause death. In medicine and public health, it typically refers to how likely a specific illness or toxic exposure is to kill. A disease with high lethality kills a large proportion of the people it affects, while a disease with low lethality may infect many people but rarely proves fatal. The concept applies across epidemiology, toxicology, and biology, each with its own way of measuring just how deadly something is.
Lethality vs. Mortality Rate
These two terms are easy to confuse, but they measure different things. A mortality rate tracks how frequently death occurs in an entire population over a set period, regardless of cause. Lethality, by contrast, zooms in on people who already have a particular condition and asks: of those affected, how many die?
The formal epidemiological term for lethality is the case fatality rate (CFR). It’s calculated by dividing the number of deaths from a disease by the total number of confirmed cases of that disease, then expressing the result as a percentage. A CFR of 60% means that 60 out of every 100 people diagnosed with the condition die from it. A related but distinct measure, the infection fatality rate (IFR), estimates deaths among all infected individuals, including those who were never diagnosed. The IFR is almost always lower than the CFR because it accounts for mild or asymptomatic cases that never show up in official counts. During the COVID-19 pandemic, the World Health Organization noted that the true level of transmission was frequently underestimated because many infections went undetected, making the IFR significantly harder to pin down than the CFR.
How Lethality Is Measured for Toxic Substances
Outside of infectious disease, lethality is most commonly quantified using a value called the LD50, short for “median lethal dose.” This is the dose of a chemical or toxin that kills 50% of a test population under controlled conditions. It’s expressed in milligrams of substance per kilogram of body weight (mg/kg). The lower the LD50, the more potent and dangerous the substance. A pesticide with an oral LD50 of 5 mg/kg, for example, is 100 times more toxic than one with an LD50 of 500 mg/kg.
LD50 values provide a standardized way to compare the acute danger of different chemicals, venoms, and toxins on a single scale. They reflect short-term exposure risk rather than long-term or cumulative harm. Botulinum toxin, produced by the bacterium Clostridium botulinum, is one of the most lethal known substances by this measure. It works by blocking the release of chemical signals between nerves and muscles, leading to paralysis and respiratory failure at extraordinarily small doses.
What Makes a Pathogen Lethal
A pathogen’s lethality depends on specific biological tools it carries. Many deadly bacteria produce toxins that rupture host cells, destroy tissue, or hijack normal body functions. Viruses, meanwhile, can be lethal because of their ability to target critical organs and evade the immune system. Some viruses carry genes that let them slip past the body’s defenses, infecting cells in the lungs, brain, or liver before the immune response can mount an effective counterattack.
The body’s own immune reaction can also drive lethality. In the early stages of a serious infection, immune cells ramp up production of inflammatory signaling molecules. When this response spirals out of control, it damages the body’s own tissues and organs. This runaway inflammation is a major contributor to death in severe cases of influenza, sepsis, and other infections where the immune system essentially overreacts to the threat.
Why the Same Disease Kills Some People and Not Others
Lethality is not fixed. The same pathogen can be mild in one person and fatal in another, depending on host factors. Age is one of the strongest predictors: very young children and older adults tend to have weaker or less adaptable immune responses. Pre-existing conditions like diabetes, heart disease, or lung disease reduce the body’s ability to tolerate the stress of infection. Genetics also play a role, influencing how efficiently your immune system recognizes and fights specific invaders.
Even the composition of your gut microbiome appears to matter. Research in experimental host-pathogen systems has shown that organisms previously colonized with certain beneficial microbes survive pathogen infections at higher rates. This helps explain why two seemingly similar individuals can have dramatically different outcomes from the same disease.
Examples Across the Lethality Spectrum
Diseases range enormously in their lethality. At the extreme end, rabies is virtually 100% fatal once symptoms appear and the virus reaches the central nervous system. This makes it one of the deadliest known infections by case fatality rate, though it kills relatively few people globally each year because effective post-exposure treatment exists. Ebola virus disease has historically shown CFRs between 25% and 90% depending on the outbreak and strain. Seasonal influenza, by comparison, has a CFR well under 1%, yet it causes far more total deaths worldwide because it infects millions of people annually.
This distinction matters. A highly lethal disease that spreads poorly may cause fewer total deaths than a mildly lethal disease that spreads easily. Lethality alone doesn’t capture the full danger of an outbreak; you also need to know how transmissible the pathogen is and how large the affected population will be.
The Evolutionary Tension Between Lethality and Spread
Biologists have long debated why pathogens don’t simply evolve to become as deadly as possible. The prevailing theory, known as the trade-off hypothesis, suggests that lethality comes at a cost to transmission. A pathogen that kills its host too quickly may not have enough time to spread to new hosts. Conversely, a pathogen that keeps its host alive and mobile has more opportunities to transmit. This creates evolutionary pressure toward a “sweet spot” where the pathogen is harmful enough to replicate efficiently but not so lethal that it burns through its host population.
The reality is more complicated than this clean framework suggests. Within-host competition between pathogen strains, interactions with the immune system, and shifting transmission routes all influence how lethality evolves. A pathogen that spreads through contaminated water, for instance, may not face the same pressure to keep its host mobile as one that spreads through respiratory droplets. The trade-off exists, but its shape varies dramatically from one pathogen to another, which is why sweeping predictions about how dangerous a new disease will become are so difficult to make.